Skip to main content
Premium Trial:

Request an Annual Quote

BioSource Regains Nasdaq Compliance, Will Resume Trading July 5

NEW YORK, June 30 (GenomeWeb News) - BioSource International has regained compliance with the Nasdaq and will resume trading on the exchange July 5, the company said today.


As GenomeWeb News reported, BioSource  received  a notice from the exchange in May indicating that the company was not in compliance with its requirements for continued listing because it failed to file a first-quarter financial report in a timely manner.


The company said at the time that the notice indicated its stock would be delisted if a financial report were not filed by July 3. BioSource filed its first-quarter return on June 28 and has received notification from the Nasdaq Office of General Counsel, Listing Qualifications Hearings "confirming compliance with SEC filing requirements and all other requirements for continued listing on the Nasdaq National Market."


The stock had been trading under the amended symbol "BIOIE" since May 27 after BioSource received the delisting notice.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.